LINDA KNIGHT-NELSON: Open Payments
NPI 1952425183 · CARROLLTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$263 in 12 payments from 7 companies in 2025. Trend: 2023 $339 · 2024 $241 · 2025 $263
Food & beverage: $263
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $74 |
| Teva Pharmaceuticals USA, Inc. | 3 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Lundbeck LLC | 1 | $33 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
| Alkermes, Inc. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $14 |
Products named: INGREZZA, ABILIFY MAINTENA, COBENFY, AUSTEDO XR, ARISTADA, UZEDY, ABILIFY ASIMTUFII, Auvelity.
Industry payments across GA — which companies pay providers there.
